1,3-Benzodioxolyl-N-methylpentanamine
|  | |
| Names | |
|---|---|
| Preferred IUPAC name 1-(2H-1,3-Benzodioxol-5-yl)-N-methylpentan-2-amine | |
| Other names 3,4-Methylenedioxy-α-propyl-N-methyl-2-phenethylamine | |
| Identifiers | |
| CAS Number | |
| 3D model (JSmol) | |
| ChemSpider | |
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| InChI 
 | |
| SMILES 
 | |
| Properties | |
| Chemical formula | C13H19NO2 | 
| Molar mass | 221.30 g/mol | 
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
N-Methyl-1,3-benzodioxolylpentanamine (MBDP; Methyl-K, UWA-091), also known as 3,4-methylenedioxy-α-propyl-N-methylphenethylamine, is a psychoactive drug of the phenethylamine chemical class. It is the N-methyl analogue of 1,3-benzodioxolylpentanamine (BDP; K). Methyl-K was first synthesized by Alexander Shulgin ("Sasha" Shulgin). In his book PiHKAL ("Phenethylamines i Have Known And Loved"), the minimum dosage is listed as 100 mg, and the duration is unknown.[1] Very little is known about the pharmacology, pharmacokinetics, effects, and toxicity of Methyl-K.
Legality
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]
See also
- Pentylone (bk-MBDP)
- Ethylbenzodioxolylpentanamine (EBDP; Ethyl-K)
- Methylbenzodioxolylbutanamine (MBDB; Methyl-J)
- UWA-101
References
- ↑ Methyl-K entry in PiHKAL
- ↑ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.
    This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
